The Department of Pharmaceutical Sciences at WSU Spokane is dedicated to advancing pharmaceutical science through research and education.
Research areas include pharmacogenetics, pharmacogenomics and proteomics, drug development and novel targets, and drug delivery mechanisms including and nanotechnology.
Research themes include studies of drug metabolism, cancer, tobacco biomarkers and cessation, cell signaling, rheumatoid arthritis and inflammation, and aging.
We are committed to developing outstanding health care professionals by educating the next generation of pharmacists in the WSU PharmD Program. The Department of Pharmaceutical Sciences teaches courses in Integrated Pharmacology, Pharmacokinetics, Pharmaceutics, Compounding, Drug Development, and Pharmacogenomics, and actively participates in the training of PharmD students in research.
We are also committed to educating the next generation of researchers through the PhD in Pharmaceutical Sciences and Molecular Medicine Graduate Program. Students are prepared for careers in academia, science and health care research through rigorous coursework and extensive laboratory experience. Students work alongside faculty mentors within established laboratories of specialized and focused research. See Graduate Programs for more details.
The department is also focused on the training of students in the PharmD/PhD Program. This program is geared to enable PharmD students to obtain both their PharmD and a PhD in Pharmaceutical Sciences and Molecular Medicine in a timely manner.
Meet the Interim Chair
Dr. Meier’s laboratory studies the molecular pharmacology of signal transduction, with a recent focus on GPCR receptor-mediated mechanisms by which omega-3 fatty acids inhibit the growth of certain cancers. Model systems include several types of cancer cells, including prostate and breast cancer. There is particular interest in lysophosphatidic acid (LPA), a ligand for GPCRs, as an autocrine and paracrine mediator of growth and inflammation. Other interests include proteins involved in adhesion signaling (e.g., FAK, CCNs) and their regulation by LPA, epidermal growth factor, and other growth factors.
See Dr. Meier’s faculty bio page for more details.